TGA registers new GLP-1 pill


The TGA has just registered Lilly’s GLP-1 pill, Foundayo (orforglipron), for the treatment of obesity and type 2 diabetes With stock to arrive in the coming days, Foundayo will be the first GLP-1 pill available in Australia, Lilly says. The announcement comes shortly after the Therapeutic Goods Administration green-lit Novo Nordisk’s Wegovy (semaglutide) tablet to

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pattern of shortages must be fixed: Ruston
Next More than 24 million illegal products seized in 2025/26: TGA